{"id":6927,"date":"2002-11-13T14:42:05","date_gmt":"2002-11-13T13:42:05","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=6927"},"modified":"2014-06-03T17:36:02","modified_gmt":"2014-06-03T17:36:02","slug":"42nd-interscience-conference-on-antimicrobial-agents-and-chemotherapy-icaac-san-diego-27-30-september-2002","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/6927","title":{"rendered":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, 27-30 September 2002"},"content":{"rendered":"<p><strong><a href=\"https:\/\/i-base.info\/htb\/keyword\/icaac-42nd-2002\">Reports from the conference<\/a><\/strong>.<\/p>\n<ul>\n<li><a title=\"Permanent link to Immunology and treatment interruption data presented at the 42nd ICAAC\" href=\"https:\/\/i-base.info\/htb\/6925\" rel=\"bookmark\">Immunology and treatment interruption data presented at the 42nd ICAAC<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Treatment interruptions may result in poor T-cell recovery in patients with nadir CD+ count &lt;50 cells\/mm3\" href=\"https:\/\/i-base.info\/htb\/6923\" rel=\"bookmark\">Treatment interruptions may result in poor T-cell recovery in patients with nadir CD+ count &lt;50 cells\/mm3<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Treatment interruptions are safe in patients with CD4+ count between 300 to 500 cells\/mm3 and viral loads lower than 70,000 copies\/mL\" href=\"https:\/\/i-base.info\/htb\/6921\" rel=\"bookmark\">Treatment interruptions are safe in patients with CD4+ count between 300 to 500 cells\/mm3 and viral loads lower than 70,000 copies\/mL<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Topical transdermal testosterone gel offers significant clinical benefits in hypogonadal HIV-positive patients\" href=\"https:\/\/i-base.info\/htb\/6919\" rel=\"bookmark\">Topical transdermal testosterone gel offers significant clinical benefits in hypogonadal HIV-positive patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to BMS experimental PI atazanavir shows potency comparable to NNRTI efavirenz among treatment-na\u00efve HIV patients\" href=\"https:\/\/i-base.info\/htb\/6917\" rel=\"bookmark\">BMS experimental PI atazanavir shows potency comparable to NNRTI efavirenz among treatment-na\u00efve HIV patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Adverse drug reactions and lipodystrophy in children\" href=\"https:\/\/i-base.info\/htb\/6915\" rel=\"bookmark\">Adverse drug reactions and lipodystrophy in children<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Study suggests Kaletra\/Combivir is better tolerated PEP than Combivir\/nelfinavir\" href=\"https:\/\/i-base.info\/htb\/6913\" rel=\"bookmark\">Study suggests Kaletra\/Combivir is better tolerated PEP than Combivir\/nelfinavir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Novel approaches to the inhibition of HIV\" href=\"https:\/\/i-base.info\/htb\/6911\" rel=\"bookmark\">Novel approaches to the inhibition of HIV<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lipodystrophy and adverse drug reaction data presented at the 42nd ICAAC\" href=\"https:\/\/i-base.info\/htb\/6909\" rel=\"bookmark\">Lipodystrophy and adverse drug reaction data presented at the 42nd ICAAC<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Reports from the conference. Immunology and treatment interruption data presented at the 42nd ICAAC Treatment interruptions may result in poor T-cell recovery in patients with nadir CD+ count &lt;50 cells\/mm3 Treatment interruptions are safe in patients with CD4+ count between &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,97],"class_list":["post-6927","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-icaac-42nd-2002"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=6927"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6927\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=6927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=6927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=6927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}